Israel Englander Cytek Biosciences, Inc. Transaction History
Millennium Management LLC
- $213 Billion
- Q3 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,418,382 shares of CTKB stock, worth $18.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,418,382
Previous 924,772
269.65%
Holding current value
$18.8 Million
Previous $3.14 Million
277.26%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CTKB
# of Institutions
151Shares Held
73MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$93.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.93MShares$38.1 Million0.0% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$36.6 Million0.69% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.96MShares$27.3 Million0.74% of portfolio
-
State Street Corp Boston, MA4.08MShares$22.5 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $740M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...